- Home
- IMCR vs EPC Comparison
IMCR vs EPC Comparison
Compare IMCR & EPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- EPC
- Stock Information
- Founded
- IMCR 2008
- EPC 1999
- Country
- IMCR United Kingdom
- EPC United States
- Employees
- IMCR N/A
- EPC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- EPC Package Goods/Cosmetics
- Sector
- IMCR Health Care
- EPC Consumer Discretionary
- Exchange
- IMCR Nasdaq
- EPC Nasdaq
- Market Cap
- IMCR 1.5B
- EPC 1.4B
- IPO Year
- IMCR 2021
- EPC 2000
- Fundamental
- Price
- IMCR $32.75
- EPC $24.80
- Analyst Decision
- IMCR Buy
- EPC Buy
- Analyst Count
- IMCR 10
- EPC 7
- Target Price
- IMCR $58.13
- EPC $33.00
- AVG Volume (30 Days)
- IMCR 439.6K
- EPC 780.3K
- Earning Date
- IMCR 08-07-2025
- EPC 08-05-2025
- Dividend Yield
- IMCR N/A
- EPC 2.42%
- EPS Growth
- IMCR N/A
- EPC N/A
- EPS
- IMCR N/A
- EPC 1.72
- Revenue
- IMCR $333,581,000.00
- EPC $2,224,500,000.00
- Revenue This Year
- IMCR $26.82
- EPC $0.90
- Revenue Next Year
- IMCR $8.15
- EPC $2.33
- P/E Ratio
- IMCR N/A
- EPC $14.42
- Revenue Growth
- IMCR 25.75
- EPC N/A
- 52 Week Low
- IMCR $23.15
- EPC $22.61
- 52 Week High
- IMCR $41.54
- EPC $41.50
- Technical
- Relative Strength Index (RSI)
- IMCR 49.96
- EPC 47.55
- Support Level
- IMCR $30.76
- EPC $23.05
- Resistance Level
- IMCR $32.55
- EPC $25.12
- Average True Range (ATR)
- IMCR 1.49
- EPC 0.82
- MACD
- IMCR -0.25
- EPC 0.22
- Stochastic Oscillator
- IMCR 32.68
- EPC 82.02
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About EPC Edgewell Personal Care Company
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.